FDA Inspection 1238625 — CARLISLE MEDICAL TECHNOLOGIES(DONGGUAN) CO., LTD
The FDA completed an inspection of CARLISLE MEDICAL TECHNOLOGIES(DONGGUAN) CO., LTD on April 17, 2024 in Dongguan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Dongguan (China)